Neurosense Therapeutics Ltd(NRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NRSN Neurosense Therapeutics Ltd

已收盘 11-22 16:00:00 EST

0.9000

-0.0200

-2.17%

盘后0.9000

+0.00000.00%

19:46 EST

最高0.9571	最低0.8505	成交量11.82万
今开0.9200	昨收0.9200	日振幅11.58%
总市值1,752万	流通市值1,307万	总股本1,947万
成交额10.33万	换手率0.81%	流通股本1,452万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NRSN","market":"US","secType":"STK","nameCN":"Neurosense Therapeutics Ltd","latestPrice":0.9,"timestamp":1732309200000,"preClose":0.92,"halted":0,"volume":118157,"hourTrading":{"tag":"盘后","latestPrice":0.9,"preClose":0.9,"latestTime":"19:46 EST","volume":632,"amount":568.2028,"timestamp":1732322774455},"delay":0,"floatShares":14519885,"shares":19471006,"eps":-0.608848,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.02,"latestTime":"11-22 16:00:00 EST","open":0.92,"high":0.95705,"low":0.8505,"amount":103267.6937747,"amplitude":0.115815,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.608848,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1639026000000,"adjPreClose":0.92,"postHourTrading":{"tag":"盘后","latestPrice":0.9,"preClose":0.9,"latestTime":"19:46 EST","volume":632,"amount":568.2028,"timestamp":1732322774455},"volumeRatio":0.73215},"requestUrl":"/m/hq/s/NRSN","defaultTab":"news","newsList":[{"id":"2485446466","title":"Neurosense Therapeutics Ltd.盘中异动 股价大跌8.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485446466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485446466?lang=zh_cn&edition=full","pubTime":"2024-11-22 02:35","pubTimestamp":1732214140,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日02时35分，Neurosense Therapeutics Ltd.股票出现波动，股价大幅下挫8.01%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.76%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112202354098e43fd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112202354098e43fd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"gpt_icon":0},{"id":"2484381110","title":"Neurosense Therapeutics Ltd.盘中异动 大幅跳水5.38%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484381110","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484381110?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:47","pubTimestamp":1732114076,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时47分，Neurosense Therapeutics Ltd.股票出现异动，股价大幅跳水5.38%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.34%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120224757abd23a4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120224757abd23a4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRSN","LENZ"],"gpt_icon":0},{"id":"2484973746","title":"Neurosense Therapeutics Ltd.盘中异动 股价大跌5.93%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484973746","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484973746?lang=zh_cn&edition=full","pubTime":"2024-11-20 01:37","pubTimestamp":1732037878,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日01时37分，Neurosense Therapeutics Ltd.股票出现异动，股价快速跳水5.93%。截至发稿，该股报1.11美元/股，成交量9.1897万股，换手率0.46%，振幅4.24%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为1.10%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120013759abcfbb90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120013759abcfbb90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRSN"],"gpt_icon":0},{"id":"2484602613","title":"Neurosense Therapeutics Ltd.盘中异动 下午盘急速下挫5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484602613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484602613?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:29","pubTimestamp":1731954563,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时29分，Neurosense Therapeutics Ltd.股票出现波动，股价急速下跌5.69%。截至发稿，该股报1.16美元/股，成交量6.1616万股，换手率0.31%，振幅7.72%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.01%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119022925abcd115b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119022925abcd115b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRSN","LENZ"],"gpt_icon":0},{"id":"2480987581","title":"Neurosense Therapeutics Ltd.盘中异动 股价大跌5.98%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480987581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480987581?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:37","pubTimestamp":1730731053,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时37分，Neurosense Therapeutics Ltd.股票出现异动，股价大幅下跌5.98%。截至发稿，该股报1.19美元/股，成交量4420股，换手率0.02%，振幅2.36%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.16%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223734a2154b85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223734a2154b85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRSN","LENZ"],"gpt_icon":0},{"id":"2480837244","title":"Neurosense Therapeutics Ltd.盘中异动 下午盘股价大涨5.60%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480837244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480837244?lang=zh_cn&edition=full","pubTime":"2024-11-02 01:23","pubTimestamp":1730481830,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日01时23分，Neurosense Therapeutics Ltd.股票出现异动，股价急速拉升5.60%。截至发稿，该股报1.32美元/股，成交量12.1286万股，换手率0.61%，振幅5.60%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.57%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110201235098e40104&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110201235098e40104&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","LENZ","BK4139"],"gpt_icon":0},{"id":"2479157034","title":"Neurosense Therapeutics Ltd.盘中异动 早盘急速下挫6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479157034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479157034?lang=zh_cn&edition=full","pubTime":"2024-10-31 23:00","pubTimestamp":1730386803,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日23时00分，Neurosense Therapeutics Ltd.股票出现波动，股价急速跳水6.92%。截至发稿，该股报1.21美元/股，成交量2.512万股，换手率0.13%，振幅6.15%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为3.42%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103123000398e3fc22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103123000398e3fc22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRSN"],"gpt_icon":0},{"id":"2479797236","title":"Neurosense Therapeutics Ltd.盘中异动 急速跳水5.93%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479797236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479797236?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:46","pubTimestamp":1730220390,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时46分，Neurosense Therapeutics Ltd.股票出现波动，股价快速下跌5.93%。截至发稿，该股报1.27美元/股，成交量6.2571万股，换手率0.32%，振幅6.67%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.39%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000463198e3f282&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000463198e3f282&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRSN","LENZ"],"gpt_icon":0},{"id":"2478486097","title":"Neurosense Therapeutics Ltd.盘中异动 急速上涨5.51%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478486097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478486097?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:38","pubTimestamp":1730122691,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时38分，Neurosense Therapeutics Ltd.股票出现异动，股价急速上涨5.51%。截至发稿，该股报1.34美元/股，成交量12.5679万股，换手率0.63%，振幅2.42%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.32%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213812971a2a35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213812971a2a35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"gpt_icon":0},{"id":"2478935097","title":"Neurosense Therapeutics Ltd.盘中异动 早盘快速上涨6.20%报1.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478935097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478935097?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:54","pubTimestamp":1729864477,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时54分，Neurosense Therapeutics Ltd.股票出现异动，股价快速上涨6.20%。截至发稿，该股报1.29美元/股，成交量2288股，换手率0.01%，振幅2.48%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.64%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521543798e3e823&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521543798e3e823&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"gpt_icon":0},{"id":"2477315066","title":"Neurosense Therapeutics Ltd.盘中异动 早盘大幅下跌5.22%报1.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477315066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477315066?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:30","pubTimestamp":1729776650,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时30分，Neurosense Therapeutics Ltd.股票出现波动，股价大幅下挫5.22%。截至发稿，该股报1.09美元/股，成交量2.0416万股，换手率0.10%，振幅0.00%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.00%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024213050ab70a2bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024213050ab70a2bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"gpt_icon":0},{"id":"2476481273","title":"Neurosense Therapeutics Ltd.盘中异动 股价大涨7.20%报1.050美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476481273","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476481273?lang=zh_cn&edition=full","pubTime":"2024-10-18 02:12","pubTimestamp":1729188723,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日02时12分，Neurosense Therapeutics Ltd.股票出现异动，股价急速上涨7.20%。截至发稿，该股报1.050美元/股，成交量4.7913万股，换手率0.24%，振幅9.44%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.82%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018021203a1e17139&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018021203a1e17139&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRSN"],"gpt_icon":0},{"id":"2475176688","title":"Neurosense Therapeutics Ltd.盘中异动 早盘股价大涨11.93%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475176688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475176688?lang=zh_cn&edition=full","pubTime":"2024-10-15 21:31","pubTimestamp":1728999066,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日21时31分，Neurosense Therapeutics Ltd.股票出现异动，股价大幅拉升11.93%。截至发稿，该股报1.22美元/股，成交量2.5468万股，换手率0.13%，振幅5.50%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.11%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410152131069f44e465&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410152131069f44e465&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRSN","LENZ"],"gpt_icon":0},{"id":"2474907050","title":"Neurosense Therapeutics Ltd.盘中异动 早盘股价大跌5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474907050","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474907050?lang=zh_cn&edition=full","pubTime":"2024-10-11 22:07","pubTimestamp":1728655679,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日22时07分，Neurosense Therapeutics Ltd.股票出现异动，股价快速跳水5.74%。截至发稿，该股报1.15美元/股，成交量5.9832万股，换手率0.30%，振幅5.74%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.47%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011220759a1e003ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011220759a1e003ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"gpt_icon":0},{"id":"2472375268","title":"Neurosense Therapeutics Ltd.盘中异动 早盘急速下挫7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472375268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472375268?lang=zh_cn&edition=full","pubTime":"2024-10-01 21:37","pubTimestamp":1727789822,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日21时37分，Neurosense Therapeutics Ltd.股票出现异动，股价快速跳水7.09%。截至发稿，该股报1.18美元/股，成交量7917股，换手率0.04%，振幅1.57%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.16%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001213703ab675003&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001213703ab675003&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","LENZ","BK4139"],"gpt_icon":0},{"id":"2471866033","title":"Neurosense Therapeutics Ltd.盘中异动 快速拉升5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471866033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471866033?lang=zh_cn&edition=full","pubTime":"2024-09-30 22:02","pubTimestamp":1727704940,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日22时02分，Neurosense Therapeutics Ltd.股票出现波动，股价急速拉升5.91%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.40%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930220220a1ddb5b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930220220a1ddb5b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","LENZ","BK4139"],"gpt_icon":0},{"id":"2469494396","title":"Neurosense Therapeutics Ltd.盘中异动 早盘股价大跌5.87%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469494396","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469494396?lang=zh_cn&edition=full","pubTime":"2024-09-24 21:43","pubTimestamp":1727185416,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日21时43分，Neurosense Therapeutics Ltd.股票出现异动，股价急速下跌5.87%。截至发稿，该股报1.22美元/股，成交量26.8782万股，换手率1.38%，振幅2.86%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.98%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924214336ab65a5ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924214336ab65a5ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","BK4139","LENZ"],"gpt_icon":0},{"id":"2468629384","title":"Neurosense Therapeutics Ltd.盘中异动 股价大跌7.41%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468629384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468629384?lang=zh_cn&edition=full","pubTime":"2024-09-20 21:31","pubTimestamp":1726839072,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日21时31分，Neurosense Therapeutics Ltd.股票出现波动，股价大幅跳水7.41%。截至发稿，该股报1.25美元/股，成交量4886股，换手率0.03%，振幅0.00%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.92%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202131149719c00e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202131149719c00e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRSN","LENZ"],"gpt_icon":0},{"id":"2461881541","title":"Neurosense Therapeutics Ltd.盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461881541","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461881541?lang=zh_cn&edition=full","pubTime":"2024-08-21 00:22","pubTimestamp":1724170924,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日00时22分，Neurosense Therapeutics Ltd.股票出现异动，股价急速拉升5.23%。截至发稿，该股报0.806美元/股，成交量5.4151万股，换手率0.29%，振幅6.02%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.18%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821002204a1d53f26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821002204a1d53f26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRSN"],"gpt_icon":0},{"id":"2459320243","title":"Neurosense Therapeutics Ltd.盘中异动 早盘大幅跳水5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459320243","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459320243?lang=zh_cn&edition=full","pubTime":"2024-08-16 22:35","pubTimestamp":1723818901,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日22时35分，Neurosense Therapeutics Ltd.股票出现波动，股价大幅跳水5.39%。截至发稿，该股报0.700美元/股，成交量9644股，换手率0.05%，振幅5.39%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.53%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408162235019f3184f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408162235019f3184f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurosense-tx.com","stockEarnings":[{"period":"1week","weight":-0.2923},{"period":"1month","weight":-0.2},{"period":"3month","weight":0.1084},{"period":"6month","weight":-0.2117},{"period":"1year","weight":0.4815},{"period":"ytd","weight":0.172}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NeuroSense Therapeutics Ltd.于2017年2月13日在以色列注册成立。该公司是一家临床阶段的生物技术公司，专注于发现和开发针对神经退行性疾病患者的治疗方法，包括肌萎缩性侧索硬化症（ALS）、阿尔茨海默病（AD）和帕金森病（PD）。公司的主要候选治疗药物PrimeC是一种新型的缓释口服制剂，由两种FDA批准的药物环丙沙星和塞来昔布组成的固定剂量组合。PrimeC旨在通过调节microRNA合成、铁积累和神经炎症来治疗ALS，所有这些都是ALS病理的标志。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.221221},{"month":2,"riseRate":1,"avgChangeRate":0.311932},{"month":3,"riseRate":0.666667,"avgChangeRate":0.159968},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.220216},{"month":5,"riseRate":0,"avgChangeRate":-0.196146},{"month":6,"riseRate":0.666667,"avgChangeRate":0.463109},{"month":7,"riseRate":0,"avgChangeRate":-0.298623},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.020927},{"month":9,"riseRate":0.333333,"avgChangeRate":0.033411},{"month":10,"riseRate":0,"avgChangeRate":-0.15772},{"month":11,"riseRate":0.666667,"avgChangeRate":0.537232},{"month":12,"riseRate":0,"avgChangeRate":-0.341086}],"exchange":"NASDAQ","name":"Neurosense Therapeutics Ltd","nameEN":"Neurosense Therapeutics Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Neurosense Therapeutics Ltd(NRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Neurosense Therapeutics Ltd(NRSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Neurosense Therapeutics Ltd,NRSN,Neurosense Therapeutics Ltd股票,Neurosense Therapeutics Ltd股票老虎,Neurosense Therapeutics Ltd股票老虎国际,Neurosense Therapeutics Ltd行情,Neurosense Therapeutics Ltd股票行情,Neurosense Therapeutics Ltd股价,Neurosense Therapeutics Ltd股市,Neurosense Therapeutics Ltd股票价格,Neurosense Therapeutics Ltd股票交易,Neurosense Therapeutics Ltd股票购买,Neurosense Therapeutics Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Neurosense Therapeutics Ltd(NRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Neurosense Therapeutics Ltd(NRSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}